Company Filing History:
3 out of 6 
1 out of 832,961 Years Active: 2021-2023
Title: Paul Seaman: Innovator in Microparticle Technology
Introduction
Paul Seaman is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of microparticle technology, holding a total of 4 patents. His work focuses on innovative processes and apparatuses that enhance the production of solid polymeric microparticles.
Latest Patents
One of his latest patents is a microparticle production process and apparatus. This invention provides an apparatus for producing solid polymeric microparticles, which includes a plurality of liquid droplet generators for forming liquid droplets of a first liquid. Additionally, it features a nozzle for forming a jet of a second liquid, arranged such that the liquid droplets pass through a gas into the jet of the second liquid. The process involves providing a first liquid with a biocompatible polymer and generating liquid droplets that contact the jet of the second liquid, resulting in the formation of solid microparticles.
Another significant patent is for sustained release cyclosporine-loaded microparticles. This controlled release pharmaceutical formulation comprises cyclosporine-loaded microparticles made from a bioresorbable polymer, specifically poly(D,L-lactide). The mean diameter of these microparticles ranges from 20 µm to 40 µm, and they have medical applications, particularly in the treatment of uveitis.
Career Highlights
Throughout his career, Paul Seaman has worked with various companies, including Midatech Pharma (Wales) Limited. His expertise in microparticle technology has positioned him as a key figure in the pharmaceutical and biomedical fields.
Collaborations
Paul has collaborated with notable professionals in his field, including Huw Jones and Liam McAleer. Their combined efforts have contributed to advancements in microparticle production and applications.
Conclusion
Paul Seaman's innovative work in microparticle technology has led to significant advancements in pharmaceutical formulations. His patents reflect a commitment to improving medical treatments through cutting-edge technology.